| Rachel Ann Anderson, PA-C | |
|
850 E 1200 N, Logan, UT 84322-3657 | |
| (435) 797-1660 | |
| Not Available |
| Full Name | Rachel Ann Anderson |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Location | 850 E 1200 N, Logan, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326551730 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 12110425-1206 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Rachel Ann Anderson, PA-C Po Box 27128, Slc, UT 84127-0128 Ph: (435) 797-1660 | Rachel Ann Anderson, PA-C 850 E 1200 N, Logan, UT 84322-3657 Ph: (435) 797-1660 |
News Archive
Women with bulimia nervosa appear to respond more impulsively during psychological testing than those without eating disorders, and brain scans show differences in areas responsible for regulating behavior, according to a report in the January issue of Archives of General Psychiatry , one of the JAMA/Archives journals.
Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that its researchers have demonstrated the ability of the Aethlon Hemopurifier® to capture immunosuppressive exosomes derived from individuals with metastatic melanoma.
While low-level shoulder separations can commonly be treated nonsurgically and high-level injuries often require surgery, a literature review published in the April 2009 issue of the Journal of the American Academy of Orthopaedic Surgeons (JAAOS) finds that many surgeons still disagree on the best course of treatment for those injuries that fall in between.
Palatin Technologies, Inc. today announced the completion of first cohort dosing in a placebo-controlled, multiple dose study of bremelanotide, its experimental treatment for sexual dysfunction. The primary endpoint in this double-blind safety study is evaluation of blood pressure effects of subcutaneous bremelanotide in men between 45 and 65 years old. The study will also evaluate consistency of plasma exposure of bremelanotide given as repeated subcutaneous injections.
› Verified 7 days ago
Adrienne Mcmaster, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2380 N 400 E Ste B, Logan, UT 84341 Phone: 435-752-5741 | |
Mr. Tyson Anderson Cluff, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-716-2800 | |
Thomas W Price, PA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 500 E 1400 N, Logan, UT 84341 Phone: 435-716-5478 | |
Benjamin Seale, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1350 N 500 E, Logan, UT 84341 Phone: 435-716-2800 | |
Kelsey Thorne, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 2245 N 400 E Ste 201, Logan, UT 84341 Phone: 435-787-7001 Fax: 801-216-8357 | |
Christopher Groberg, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 1300 N 500 E Ste 320, Logan, UT 84341 Phone: 435-716-2200 Fax: 435-716-2220 | |
Mr. Colby J Andersen, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 550 E 1400 N, Logan, UT 84341 Phone: 435-752-7060 Fax: 801-394-4609 |